Literature DB >> 15580208

Clinical and behavioral features of patients with Borjeson-Forssman-Lehmann syndrome with mutations in PHF6.

Jeannie Visootsak1, Beth Rosner, Elisabeth Dykens, Charles Schwartz, Kimberly Hahn, Susan M White, Roxy Szeftel, John M Graham.   

Abstract

OBJECTIVE: To describe clinical and behavioral features of 10 men from 2 families with Borjeson-Forssman-Lehmann syndrome (BFLS) and missense mutations in the PHF6 zinc-finger transcription factor gene. STUDY
DESIGN: BFLS behavioral features were compared with other age-matched men with other syndromes and similar intellectual functioning through the use of standardized questionnaires: the Child Behavior Checklist, the Vineland Adaptive Behavior Scales, and the Reiss Personality Profile. Participants included 10 with BFLS, 10 with Prader-Willi syndrome, and 23 with Klinefelter syndrome variants (13 with 48,XXYY, 4 with 48,XXXY, and 6 with 49,XXXXY).
RESULTS: Contrary to initial reports, our men with BFLS had no microcephaly, seizures, or short stature. They manifested deep-set eyes with large ears, coarse facial features, small external genitalia, gynecomastia, and obesity. Family A had mild to moderate mental retardation, whereas family B was more severely affected. On Vineland Adaptive Behavior Scales, men with BFLS had higher daily living and social skills than communicative skills. Men with BFLS also had lower internalizing and externalizing symptoms and appeared more social and helpful than men with Prader-Willi syndrome or Klinefelter syndrome variant.
CONCLUSIONS: Men with BFLS from 2 families with mutations in the PHF6 gene manifested distinctive clinical features and a low risk for maladaptive behaviors.

Entities:  

Mesh:

Year:  2004        PMID: 15580208     DOI: 10.1016/j.jpeds.2004.07.041

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  10 in total

1.  Mutation screening in Borjeson-Forssman-Lehmann syndrome: identification of a novel de novo PHF6 mutation in a female patient.

Authors:  J Crawford; K M Lower; R C M Hennekam; H Van Esch; A Mégarbané; S A Lynch; G Turner; J Gécz
Journal:  J Med Genet       Date:  2005-07-01       Impact factor: 6.318

2.  PHF6 Deletions May Cause Borjeson-Forssman-Lehmann Syndrome in Females.

Authors:  S Berland; K Alme; A Brendehaug; G Houge; R Hovland
Journal:  Mol Syndromol       Date:  2011-07-19

3.  Structural basis of plant homeodomain finger 6 (PHF6) recognition by the retinoblastoma binding protein 4 (RBBP4) component of the nucleosome remodeling and deacetylase (NuRD) complex.

Authors:  Zhonghua Liu; Fudong Li; Beibei Zhang; Sai Li; Jihui Wu; Yunyu Shi
Journal:  J Biol Chem       Date:  2015-01-19       Impact factor: 5.157

Review 4.  The Role of PHF6 in Hematopoiesis and Hematologic Malignancies.

Authors:  Yusra A Eisa; Ying Guo; Feng-Chun Yang
Journal:  Stem Cell Rev Rep       Date:  2022-08-26       Impact factor: 6.692

5.  Chromatin regulators and their impact on DNA repair and G2 checkpoint recovery.

Authors:  Veronique A J Smits; Ignacio Alonso-de Vega; Daniël O Warmerdam
Journal:  Cell Cycle       Date:  2020-07-30       Impact factor: 4.534

6.  Structural and functional insights into the human Börjeson-Forssman-Lehmann syndrome-associated protein PHF6.

Authors:  Zhonghua Liu; Fudong Li; Ke Ruan; Jiahai Zhang; Yide Mei; Jihui Wu; Yunyu Shi
Journal:  J Biol Chem       Date:  2014-02-19       Impact factor: 5.157

7.  PHF6 regulates cell cycle progression by suppressing ribosomal RNA synthesis.

Authors:  Jiadong Wang; Justin Wai-chung Leung; Zihua Gong; Lin Feng; Xiaobing Shi; Junjie Chen
Journal:  J Biol Chem       Date:  2012-12-10       Impact factor: 5.157

8.  The PHF6 Mutation c.1A>G; pM1V Causes Börjeson-Forsman-Lehmann Syndrome in a Family with Four Affected Young Boys.

Authors:  Anja Ernst; Vang Q Le; Allan T Højland; Inge S Pedersen; Tine H Sørensen; Lise L Bjerregaard; Troels J B Lyngbye; Ninna M Gammelager; Henrik Krarup; Michael B Petersen
Journal:  Mol Syndromol       Date:  2015-09-29

9.  Transgenic mice with an R342X mutation in Phf6 display clinical features of Börjeson-Forssman-Lehmann Syndrome.

Authors:  Raies Ahmed; Shihab Sarwar; Jinghua Hu; Valérie Cardin; Lily R Qiu; Gerardo Zapata; Lucianne Vandeleur; Keqin Yan; Jason P Lerch; Mark A Corbett; Jozef Gecz; David J Picketts
Journal:  Hum Mol Genet       Date:  2021-05-12       Impact factor: 6.150

Review 10.  Nucleolus as an emerging hub in maintenance of genome stability and cancer pathogenesis.

Authors:  Mikael S Lindström; Deana Jurada; Sladana Bursac; Ines Orsolic; Jiri Bartek; Sinisa Volarevic
Journal:  Oncogene       Date:  2018-02-12       Impact factor: 9.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.